VITARINE's TRIAMTERENE/HYDROCHLOROTHIAZIDE WILL BE ONLY GENERIC VERSION OF MYLAN's MAXZIDE ON MARKET UNTIL APRIL 17; FIRM's ANDA APPROVED DEC. 8